146 related articles for article (PubMed ID: 20488988)
1. Covering a broad dynamic range: information processing at the erythropoietin receptor.
Becker V; Schilling M; Bachmann J; Baumann U; Raue A; Maiwald T; Timmer J; Klingmüller U
Science; 2010 Jun; 328(5984):1404-8. PubMed ID: 20488988
[TBL] [Abstract][Full Text] [Related]
2. Activation and inhibition of the erythropoietin receptor by a membrane-anchored erythropoietin.
Negre O; Fusil F; Henri A; Villette JM; Leboulch P; Beuzard Y; Payen E
Exp Hematol; 2008 Apr; 36(4):412-23. PubMed ID: 18295963
[TBL] [Abstract][Full Text] [Related]
3. Localization of an essential ligand binding determinant of the human erythropoietin receptor to a domain N-terminal to the WSXWS motif: implications for soluble receptor function.
Schimmenti LA; Blechert G; Harris KW; Winkelmann JC
Exp Hematol; 1995 Dec; 23(13):1341-6. PubMed ID: 7498361
[TBL] [Abstract][Full Text] [Related]
4. The influence of domain structures on the signal transduction of chimeric receptors derived from the erythropoietin receptor.
Liu W; Kawahara M; Ueda H; Nagamune T
J Biochem; 2009 May; 145(5):575-84. PubMed ID: 19155265
[TBL] [Abstract][Full Text] [Related]
5. A "classical" homodimeric erythropoietin receptor is essential for the antiapoptotic effects of erythropoietin on differentiated neuroblastoma SH-SY5Y and pheochromocytoma PC-12 cells.
Um M; Gross AW; Lodish HF
Cell Signal; 2007 Mar; 19(3):634-45. PubMed ID: 17045782
[TBL] [Abstract][Full Text] [Related]
6. Mimicry of erythropoietin and interleukin-6 signalling by an antibody/cytokine receptor chimera in murine myeloid 32D cells.
Kawahara M; Ueda H; Tsumoto K; Kumagai I; Nagamune T
J Biochem; 2007 Apr; 141(4):563-71. PubMed ID: 17442704
[TBL] [Abstract][Full Text] [Related]
7. Erythropoietin-dependent autocrine secretion of tumor necrosis factor-alpha in hematopoietic cells modulates proliferation via MAP kinase--ERK-1/2 and does not require tyrosine docking sites in the EPO receptor.
Chen J; Jacobs-Helber SM; Barber DL; Sawyer ST
Exp Cell Res; 2004 Aug; 298(1):155-66. PubMed ID: 15242770
[TBL] [Abstract][Full Text] [Related]
8. Efficiency of signalling through cytokine receptors depends critically on receptor orientation.
Syed RS; Reid SW; Li C; Cheetham JC; Aoki KH; Liu B; Zhan H; Osslund TD; Chirino AJ; Zhang J; Finer-Moore J; Elliott S; Sitney K; Katz BA; Matthews DJ; Wendoloski JJ; Egrie J; Stroud RM
Nature; 1998 Oct; 395(6701):511-6. PubMed ID: 9774108
[TBL] [Abstract][Full Text] [Related]
9. A diversity of antibody epitopes can induce signaling through the erythropoietin receptor.
Lim AC; Ketchem RR; Borges L; Carabeo T; Carter J; Hoover JE; Hu Z; Wittekind M; Zhou H; Mehlin C
Biochemistry; 2010 May; 49(18):3797-804. PubMed ID: 20337434
[TBL] [Abstract][Full Text] [Related]
10. Packing density of the erythropoietin receptor transmembrane domain correlates with amplification of biological responses.
Becker V; Sengupta D; Ketteler R; Ullmann GM; Smith JC; Klingmüller U
Biochemistry; 2008 Nov; 47(45):11771-82. PubMed ID: 18855427
[TBL] [Abstract][Full Text] [Related]
11. The human erythropoietin receptor.
Winkelmann JC
Int J Cell Cloning; 1992 Sep; 10(5):254-61. PubMed ID: 1453011
[TBL] [Abstract][Full Text] [Related]
12. The role of asymmetric binding in ligand-receptor systems with 1:2 interaction ratio.
Míguez DG
Biophys Chem; 2010 May; 148(1-3):74-81. PubMed ID: 20332059
[TBL] [Abstract][Full Text] [Related]
13. Reactive oxygen species generated by hematopoietic cytokines play roles in activation of receptor-mediated signaling and in cell cycle progression.
Iiyama M; Kakihana K; Kurosu T; Miura O
Cell Signal; 2006 Feb; 18(2):174-82. PubMed ID: 15982852
[TBL] [Abstract][Full Text] [Related]
14. Expression pattern of erythropoietin and erythropoietin receptor in experimental model of retinal detachment.
Xie Z; Wu X; Qiu Q; Gong Y; Song Y; Gu Q; Li C
Curr Eye Res; 2007 Sep; 32(9):757-64. PubMed ID: 17882708
[TBL] [Abstract][Full Text] [Related]
15. Ligand-independent oligomerization of cell-surface erythropoietin receptor is mediated by the transmembrane domain.
Constantinescu SN; Keren T; Socolovsky M; Nam H; Henis YI; Lodish HF
Proc Natl Acad Sci U S A; 2001 Apr; 98(8):4379-84. PubMed ID: 11296286
[TBL] [Abstract][Full Text] [Related]
16. Identification of a critical ligand binding determinant of the human erythropoietin receptor. Evidence for common ligand binding motifs in the cytokine receptor family.
Middleton SA; Johnson DL; Jin R; McMahon FJ; Collins A; Tullai J; Gruninger RH; Jolliffe LK; Mulcahy LS
J Biol Chem; 1996 Jun; 271(24):14045-54. PubMed ID: 8662939
[TBL] [Abstract][Full Text] [Related]
17. A dimeric peptide with erythropoiesis-stimulating activity uniquely affects erythropoietin receptor ligation and cell surface expression.
Verma R; Green JM; Schatz PJ; Wojchowski DM
Exp Hematol; 2016 Aug; 44(8):765-769.e1. PubMed ID: 27174804
[TBL] [Abstract][Full Text] [Related]
18. Cellular trafficking and degradation of erythropoietin and novel erythropoiesis stimulating protein (NESP).
Gross AW; Lodish HF
J Biol Chem; 2006 Jan; 281(4):2024-32. PubMed ID: 16286456
[TBL] [Abstract][Full Text] [Related]
19. Predictive mathematical models of cancer signalling pathways.
Bachmann J; Raue A; Schilling M; Becker V; Timmer J; Klingmüller U
J Intern Med; 2012 Feb; 271(2):155-65. PubMed ID: 22142263
[TBL] [Abstract][Full Text] [Related]
20. Correlated receptor transport processes buffer single-cell heterogeneity.
Kallenberger SM; Unger AL; Legewie S; Lymperopoulos K; Klingmüller U; Eils R; Herten DP
PLoS Comput Biol; 2017 Sep; 13(9):e1005779. PubMed ID: 28945754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
